• APRIL 10, 2000

MFs witness surge in inflows on market pick-up

The turnaround in markets could not have come at a better time for fund managers who are witnessing some inflows...for a change.

Markets picked up smartly on Friday (April 7, 2000) by over 350 points to close at 5,220 points. Software and pharma stocks hogged the limelight, with quite a few 'A' group companies (in both sectors) hitting the upward circuit. Overall the markets rebounded 11% (from 4,700 points) to 5,220 points in just 3 days.

On Friday, equitymaster.com had opined that investors should seriously consider entering software funds. Investors who find software funds too expensive, may look at pharma funds.

Mutual funds are currently witnessing a surge in inflows, which has come as a big relief considering the redemptions that had tightened the screws on fund managers over the past few weeks. Apart from the stock market-rebound, another factor that has prompted investors to look at MFs with renewed interest, is the benefit of offsetting capital gains under Section 54EA/EB.

With the September 30, 2000, extension, investors can invest their long term capital gains in MFs by September 30, 2000 or six months from the date of sale of asset, whichever is earlier. This combined with the robust performance of the markets has made MFs a very attractive investment avenue... and investors seemed to have realised it too.

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited (Research Analyst)
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407